To purchase hard copies of this book, please email:
orders@intechopen.com
By only printing on demand InTech ensures our carbon footprint is kept to a minimum.
The data below shows the environmental impact of printing one single book:
76.19 kg wood
4.1 g CO2
69.18 ml Water
Share this page
Toxicity and Drug Testing
Edited by William Acree, ISBN 978-953-51-0004-1, Hard cover, 528 pages, Publisher: InTech, Published: February 10, 2012 under CC BY 3.0 license, in subject Infectious Diseases
DOI: 10.5772/1976
Modern drug design and testing involves experimental in vivo and in vitro measurement of the drug candidate's ADMET (adsorption, distribution, metabolism, elimination and toxicity) properties in the early stages of drug discovery. Only a small percentage of the proposed drug candidates receive government approval and reach the market place. Unfavorable pharmacokinetic properties, poor bioavailability and efficacy, low solubility, adverse side effects and toxicity concerns account for many of the drug failures encountered in the pharmaceutical industry. Authors from several countries have contributed chapters detailing regulatory policies, pharmaceutical concerns and clinical practices in their respective countries with the expectation that the open exchange of scientific results and ideas presented in this book will lead to improved pharmaceutical products.
This book is indexed in:
Book contents
- Chapter 1Blood Brain Barrier Permeation
- Chapter 2Diagnostic Accuracy and Interpretation of Urine Drug Testing for Pain Patients: An Evidence-Based Approach
- Chapter 3Experimental and Computational Methods Pertaining to Surface Tension of Pharmaceuticals
- Chapter 4Multi-Well Engineered Heart Tissue for Drug Screening and Predictive Toxicology
- Chapter 5Prediction of Partition Coefficients and Permeability of Drug Molecules in Biological Systems with Abraham Model Solute Descriptors Derived from Measured Solubilities and Water-to-Organic Solvent Partition Coefficients
- Chapter 6Variability of Plasma Methadone Concentration in Opiate Dependent Receiving Methadone: A Personalised Approach Towards Optimizing Dose
- Chapter 7Drug Synergy – Mechanisms and Methods of Analysis
- Chapter 8Herbal Medicine in the Treatment of Malaria: Vernonia amygdalina: An Overview of Evidence and Pharmacology
- Chapter 9Experimental and Computational Methods Pertaining to Drug Solubility
- Chapter 10Toxic Effects of Cadmium on Crabs and Shrimps
- Chapter 11Paraquat, Between Apoptosis and Autophagy
- Chapter 12Prediction of Toxicity, Sensory Responses and Biological Responses with the Abraham Model
- Chapter 13Mikania glomerata and M. laevigata: Clinical and Toxicological Advances
- Chapter 14Evaluation of Drug Toxicity for DNA Vaccine Candidates Against Infectious Diseases: Hepatitis C as Experimental Model
- Chapter 15Aluminium Phosphide Poisoning
- Chapter 16Application of a New Genotoxicity Test System with Human Hepatocyte Cell Lines to Improve the Risk Assessment in the Drug Development
- Chapter 17Genotoxic Impurities in Pharmaceuticals
- Chapter 18Measurement Uncertainty in Forensic Toxicology: Its Estimation, Reporting and Interpretation
- Chapter 19Toxicokinetics and Organ-Specific Toxicity
- Chapter 20Environmental Toxicants Induced Male Reproductive Disorders: Identification and Mechanism of Action
